Differential Expression of GP130 in Ejaculated Spermatozoa from Healthy Volunteers and the Patients with Asthenospermia

GUI Yao-ting,GUO Lian-dian,ZHANG Li-bing,WANG He,YU Jie,CAI Zhi-ming
DOI: https://doi.org/10.3969/j.issn.1004-3845.2005.06.004
2005-01-01
Journal of reproductive medicine
Abstract:Objective: Interleukin-6 (IL-6) shows extensive functions in the process of physiology and pathophysiology by binding to IL-6 receptor (IL-6R) and GP130. The present study is to compare the expression of IL-6, IL-6R and GP130 in ejaculated spermatozoa from healthy volunteers and the patients with asthenospermia. Methods: Semen samples were obtained from the healthy volunteers and the patients with asthenospermia from the Center for Reproductive Medicine, Peking University Shenzhen Hospital. Semen analysis was performed according to WHO criteria. The spermatozoa were collected and purified by the Percoll gradient technique to separate seminal plasma and to remove cell contamination. RT-PCR and immunocytochemistry were used to detect the expression of IL-6, IL-6R and GP130 in spermatozoa from two groups. Results: The mRNA expression of GP130, but not IL-6 and IL-6R, was detected by RT-PCR in human ejaculated spermatozoa. Compared with the healthy volunteers, the patients with asthenospermia showed a significant decrease in the expression of GP130 mRNA. To further confirm the results from RT-PCR, immunocytochemistry was used to investigate the protein expression of GP130 in human ejaculated spermatozoa. The results showed that the expression of GP130 in the patients with asthenospermia was significantly lower than that in healthy volunteers, which was similar to the results from RT-PCR. Conclusion: The expression of GP130 in ejaculated spermatozoa is significantly decreased in the patients with asthenospermia, which suggests one possible reason for the low sperm motility of the patients.
What problem does this paper attempt to address?